Tandem Diabetes Care (TNDM) News
NASDAQ: TNDMHealth CareMedical/Dental InstrumentsUSD
16.11+0.435 (+2.78%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
TNDM news summary
We found 2 recent headlines mentioning Tandem Diabetes Care (TNDM): 1 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, TNDM is up 2.78% at $16.11. The most recent story, "Is it the Right Time to Hold TNDM Stock in Your Portfolio?", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Tandem Diabetes Care headlines
- Is it the Right Time to Hold TNDM Stock in Your Portfolio?Tandem Diabetes is advancing next-generation insulin delivery technology and international expansion, but competition and supply constraints pose challenges to growth.NasdaqTNDM, ABT, GMED, PAHC
- Reasons to Retain Tandem Diabetes Stock in Your Portfolio NowTNDM's expanding pump lineup and pay-as-you-go model support growth prospects, though macro and competitive pressures remain.NasdaqTNDM, ILMN, GMED, VCYT